Veyron Pen · Retatrutide

The Veyron Pen takes the fiddliest part out of working with a freeze-dried peptide. Instead of a separate vial, a bottle of bacteriostatic water and a drawing syringe, everything is built into one device. The pen has two cartridges: one holds lyophilised retatrutide, the other holds the diluent. When you are ready, the two are combined inside the pen itself, so there is no manual mixing, no transferring between containers and far fewer steps where things can go wrong.

Inside is the same compound as our retatrutide vials: a triple agonist of the GLP-1, GIP and glucagon receptors.

Why researchers work with it

• Dual-cartridge design: powder and diluent kept apart until needed
• Combined inside the pen, with no vial or drawing syringe required
• Powder stays in its stable, freeze-dried form until activation
• Available in 10, 20, 30, 40 and 60 mg
• Use with Veyron 31G pen needles

At a glance

Every Veyron batch is checked by HPLC before it is released, and each pen ships factory-sealed, so what arrives matches what is on the label.

Veyron products are sold for research purposes only. They are not intended for human consumption, nor to diagnose, treat, cure or prevent any condition.